Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Partial Onset Seizures”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00448539
What this trial is testing

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Who this might be right for
Refractory Partial Onset Seizures
Eisai Inc. 286
Large-scale testing (Phase 3)Study completedNCT00235755
What this trial is testing

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 539
Post-approval studies (Phase 4)Study completedNCT01229735
What this trial is testing

Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Korea Co., Ltd. 343
Testing effectiveness (Phase 2)Looking for participantsNCT07219407
What this trial is testing

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Who this might be right for
Focal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more
Rapport Therapeutics Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06443463
What this trial is testing

Long-term Safety and Tolerability of BHV-7000

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 660
Testing effectiveness (Phase 2)Study completedNCT00175929
What this trial is testing

Brivaracetam in Subjects With Partial Onset Seizures

Who this might be right for
Epilepsy, Focal
UCB Pharma 157
Large-scale testing (Phase 3)Study completedNCT00772603
What this trial is testing

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Who this might be right for
Epilepsies, Partial
Supernus Pharmaceuticals, Inc. 366
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Large-scale testing (Phase 3)WithdrawnNCT00422110
What this trial is testing

Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma
Testing effectiveness (Phase 2)Study completedNCT00152451
What this trial is testing

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB S.A. - Pharma Sector 31
Large-scale testing (Phase 3)Study completedNCT00232596
What this trial is testing

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 306
Large-scale testing (Phase 3)Looking for participantsNCT06132893
What this trial is testing

Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Who this might be right for
Focal Epilepsy
Biohaven Therapeutics Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT00105040
What this trial is testing

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
UCB Pharma 87
Testing effectiveness (Phase 2)WithdrawnNCT01167335
What this trial is testing

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

Who this might be right for
Partial Onset Seizures
Novartis
Large-scale testing (Phase 3)Study completedNCT00368069
What this trial is testing

Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Who this might be right for
Epilepsy
UCB Pharma 158